Quarterly report [Sections 13 or 15(d)]

Other Items

v3.25.1
Other Items
 6 Months Ended
Mar. 31, 2025
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]  
Other Items OTHER ITEMS
Cash, Cash Equivalents, and Restricted Cash
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
March 31, 2025 September 30, 2024
(in thousands)
Cash and cash equivalents $ 108,059  $ 183,123 
Restricted cash 47,879  52,640 
Cash, cash equivalents, and restricted cash $ 155,938  $ 235,763 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Six Months Ended
March 31, 2025 March 31, 2024
(in thousands)
Interest payments $ 38,767  $ 39,946 
Income tax payments $ 70,397  $ 43,794 
Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
March 31, 2025 September 30, 2024
(in thousands)
Billed and billable receivables $ 738,932  $ 734,817 
Unbilled receivables 368,090  149,488 
Allowance for credit losses (9,618) (4,791)
Accounts receivable, net $ 1,097,404  $ 879,514 
We have a Receivables Purchase Agreement with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable balances up to a maximum amount of $200.0 million at any given time. In return for these sales, we receive a cash payment equal to the face value of the receivables less a financing charge.
We account for these transfers as sales. We have no retained interest in the transferred receivables other than administrative responsibilities, and Wells Fargo has no recourse for any credit risk. We estimate that the implicit servicing fees for an arrangement of this size and type would be immaterial.
For the six months ended March 31, 2025 and 2024, the gross fair value of accounts receivables transferred to Wells Fargo and derecognized from our balance sheet was $377.2 million and $133.0 million, respectively. In exchange for these sales, we received cash of $374.9 million and $132.2 million for the same periods, respectively. The difference, representing a loss on sale from these transfers, is included within our selling, general, and administrative expenses. We have recorded these transactions within our operating cash flows.